期刊文献+

HEPT 类似物的电子结构与抗 HIV 活性的关系研究 被引量:7

Study on the structure-activity relationships of HEPT inhibitors
原文传递
导出
摘要 目的:为了研究HEPT 类似物的电子结构与其抗HIV 活性的关系。方法:应用分子力学MM+方法,半经验量子化学MNDO 法计算了23个HEPT 类似物的优势构象和电子结构,结合数理方法得到了两个定量构效方程:(1)log1/C=5.138+0.00005823I_(C-C)+0.00004894E_e+3.747Q_(13);(2)ClogP=5.271+0.0001363I_(C-C)+0.0001134E_e-10.86Q_(S13);结果:(1)HEPT 类似物的两个苯环作为两个核的核与核之间相互作用I_(C-C)和分子总电子能E_e 是影响其log1/C 与ClogP 的主要因素,核与核之间的相互作用越强,总电子能越高,则其疏水参数和其抗HIV 活性也越强。(2)13号原子上取代基的净电荷Q_(S13)越大时,ClogP 越小。当13号原子的净电荷Q_(13)越多,其抗HIV 活性则越强。结论:HEPT 类似物的抗HIV 活性与化合物的核与核之间相互作用、总电子能及13号位的原子的净电荷成正比。 Objective:To analyze the QSAR of 23 HEPT Inhibitors.Methods:the MM+ geometry optimization and MNDO quantumchemical indexes had been performed.The significant QSAR equations can be obtained as below:(1)ClogP=5.271+1.363×10^(-4)I(c.c)+1.134×10^(-4)E_c-10.86Q_(s13);(2)1ogl/C=5.138+5.823×10^(-5)I(c-c)+4.894×10^(-5)E_e+3.747Q_(13);Results:(1)The I_(c-c)and E_e of HEPT derivatives are main factors that affect activity(logl/C)and hydrophobicity(ClogP)of their derivatives.The activi-ties and hydrophobicity of HEPT derivatives will increase with the more values of I_(c-c) and Ee of molecules.(2)ClogP of the derivativewill be less while the net charge Q_(S13) of 13-substituted group of molecule is more;logl/C of the derivative will increase while the netcharge Q_(13) of 13-atom of molecule is more.Conclusions:the anti-HIV activities of HEPT derivatives are increased with increasing ofI_(c.c),E_e,Q_(13) of compound molecules.
出处 《计算机与应用化学》 CAS CSCD 北大核心 2004年第5期665-668,共4页 Computers and Applied Chemistry
基金 国家重点基础研究"973"项目(G1998051201) 广东省科技攻关基金项目(2KB01202S)
关键词 MNDO HEPT衍生物 结构与活性 HIV HEPT derivators structure-activity relationship HIV MNDO
  • 相关文献

参考文献4

二级参考文献17

  • 1罗一帆,许旋,梁尧,蔡文正.核苷酸还原酶抑制剂抗癌活性与电子结构的关系[J].药学学报,1994,29(9):673-679. 被引量:1
  • 2王玉珠,王鹏,韩丽梅.CNDO分子轨道法研究靛玉红及其衍生物的定量构效关系[J].中国药物化学杂志,1994,4(2):105-109. 被引量:6
  • 3田发安,龚考才,李春敏.N_(1′)-甲基靛玉红肟的结构和性质研究[J].高等学校化学学报,1996,17(1):69-72. 被引量:4
  • 4王尔华.定量药物设计[M].北京:人民卫生出版社,1983.121-154.
  • 5[1]Pearl L H, Taylor W R. Nature, 1987, 329: 351-352.
  • 6[2]Babine. Bender molecular recognition of protein-ligand complexes. Chem Rev, 1997, 5:1365 - 1386.
  • 7[3]Moyle G, Gazzard B. Current knowledge and future prospects for the use of HIV protease inhibitors. Drugs, 1996, 5:701-712.
  • 8[4]Bradley D T, Hagen S, Domagala J, et al. 4-Hydroxy-5, 6-dig ydropyrones, 2.Potent Non-peptide inhibitors of HIV protease. J Med Chem, 1997, 40:3781-3792.
  • 9[5]Prasad J V N V, Kimberly S P, Elizabeth A L, et al. Novel series of achiral, low molecular weight, and potent HIV-1 protease inhibitors. J Am Chem Soc, 1994, 116:6989-6990.
  • 10[6]Vellarkand N V, Arup K G, Ganapathi R R, et al. Pysicochemical parameters for three dimensional structure directed quantitativestructure-activity relationships, 4. Additional parameters for Hydrophobic and dispersivereactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J Chem Inf Comput Sci, 1989, 29:163 - 172.

共引文献33

同被引文献73

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部